Key result
Prior statin use was the strongest predictor of future statin adherence following an acute myocardial infarction (OR 3.65), with predictive models demonstrating moderate discrimination.
Why the study?
Predictive analytic approaches needed comparison to characterize medication nonadherence and determine under which circumstances each method may be best applied.
Can predictive analytic approaches accurately characterize statin nonadherence in Medicare beneficiaries following an acute MI?
Observational (n=11,969)
Can predictive analytic approaches accurately characterize statin nonadherence in Medicare beneficiaries following an acute MI?
Odds Ratio: 3.65 (95% CI 3.34–3.98)
Predictive analytics using claims data can identify patients at risk of statin nonadherence post-MI with moderate discrimination, though no single model emerged as clearly superior.
May inform model selection for statin adherence prediction in claims data; leaves open prospective validation.
OBJECTIVE: To compare predictive analytic approaches to characterize medication nonadherence and determine under which circumstances each method may be best applied. DATA SOURCES/STUDY SETTING: Medicare Parts A, B, and D claims from 2007 to 2013. STUDY DESIGN: We evaluated three statistical techniques to predict statin adherence (proportion of days covered [PDC ≥ 80 percent]) in the year following discharge: standard logistic regression with backward selection of covariates, least absolute shrinkage and selection operator (LASSO), and random forest. We used the C-index to assess model discrimination and decile plots comparing predicted values to observed event rates to evaluate model performance. DATA EXTRACTION: We identified 11 969 beneficiaries with an acute myocardial infarction (MI)-related admission from 2007 to 2012, who filled a statin prescription at, or shortly after, discharge. PRINCIPAL FINDINGS: In all models, prior statin use was the most important predictor of future adherence (OR = 3.65, 95% CI: 3.34-3.98; OR = 3.55). Although the LASSO regression model selected nearly 90 percent of all candidate predictors, all three analytic approaches had moderate discrimination (C-index ranging from 0.664 to 0.673). CONCLUSIONS: Although none of the models emerged as clearly superior, predictive analytics could proactively determine which patients are at risk of nonadherence, thus allowing for timely engagement in adherence-improving interventions.
No takes yet. Share an insight, caveat, or question.
Zullig et al. (2019) conducted an observational in Acute myocardial infarction (n=11,969). Prior statin use vs. No prior statin use was evaluated on Statin adherence (proportion of days covered ≥ 80%) in the year following discharge (OR 3.65, 95% CI 3.34-3.98). Prior statin use was the strongest predictor of future statin adherence following an acute myocardial infarction (OR 3.65), with predictive models demonstrating moderate discrimination.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: